Ravindran Krishnan, Salem Mohamed M, Enriquez-Marulanda Alejandro, Alturki Abdulrahman Y, Moore Justin M, Thomas Ajith J, Ogilvy Christopher S
Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA; Department of Neurosurgery, National Neurosciences Institute, King Fahad Medical City, Riyadh, Saudi Arabia.
World Neurosurg. 2018 Dec;120:e1031-e1040. doi: 10.1016/j.wneu.2018.08.225. Epub 2018 Sep 7.
Very little is known about the incidence of in-stent stenosis after flow diverter treatment of intracranial aneurysms. We sought to evaluate the incidence and clinical significance of in-stent stenosis at angiographic follow-up after Pipeline embolization device (PED) placement using quantitative measures.
The clinical and radiological records from all patients undergoing PED treatment of intracranial aneurysms at a major U.S. academic center from March 2013 to July 2017 were retrospectively reviewed. A modified version of the North American Symptomatic Carotid Endarterectomy criteria was used to quantify the degree of stenosis on the most recent postprocedural angiogram. The percentage of stenosis was calculated as 1 - (narrowest vessel diameter/maximal midstent diameter within the artery) at the first follow-up angiogram. The PubMed, Web of Science, and EMBASE databases were additionally searched from inception until April 2018 for the rates of in-stent stenosis after flow diversion.
A total of 155 patients (mean age, 58.3 years; 30 males) with 162 aneurysms underwent treatment with the PED at our institution. In-stent stenosis was detected in 12 patients (7.1%) at 6 months. The mean percentage of stenosis was 39.7%. All 12 patients remained asymptomatic, except for 1 who developed hemiplegia secondary to an unrelated ischemic stroke. The aneurysm occlusion rates at 6 months were comparable between the stenosis and nonstenosis cohorts (76.9% and 71.6%, respectively). Within the stenosis cohort, further follow-up angiograms after 6 months were available for 6 patients, of whom 3 (50%) had either complete resolution or improvement. Of the 43 included studies, 28 reported on the use of the PED, with 2448 patients. The mean reported rate of in-stent stenosis after PED placement was 8.8% (range, 0%-39%).
In-stent stenosis remains a rare complication of PED placement for intracranial aneurysms. When occurring, it appears to largely be self-limiting, with a benign clinical course.
关于颅内动脉瘤血流导向治疗后支架内狭窄的发生率,人们了解甚少。我们试图采用定量方法评估使用Pipeline栓塞装置(PED)治疗后血管造影随访时支架内狭窄的发生率及临床意义。
回顾性分析2013年3月至2017年7月在美国一家大型学术中心接受颅内动脉瘤PED治疗的所有患者的临床和放射学记录。使用北美症状性颈动脉内膜切除术标准的改良版来量化最近一次术后血管造影的狭窄程度。狭窄百分比在首次随访血管造影时计算为1 -(最窄血管直径/动脉内支架中部最大直径)。另外检索PubMed、科学网和EMBASE数据库,从建库至2018年4月,查找血流导向治疗后支架内狭窄的发生率。
我们机构共有155例患者(平均年龄58.3岁;30例男性)的162个动脉瘤接受了PED治疗。6个月时在12例患者(7.1%)中检测到支架内狭窄。平均狭窄百分比为39.7%。12例患者均无症状,除1例因无关的缺血性卒中继发偏瘫。狭窄和非狭窄队列6个月时的动脉瘤闭塞率相当(分别为76.9%和71.6%)。在狭窄队列中,6例患者有6个月后的进一步随访血管造影,其中3例(50%)狭窄完全缓解或有所改善。在纳入的43项研究中,28项报告了PED的使用情况,涉及2448例患者。报告的PED置入后支架内狭窄的平均发生率为8.8%(范围0% - 39%)。
支架内狭窄仍然是颅内动脉瘤PED置入的一种罕见并发症。发生时,它似乎在很大程度上是自限性的,临床过程良性。